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Abstract
Smoking causes endothelial dysfunction and systemic microvascular disease with resultant end-organ damage in the
kidneys, eyes and heart. Little is known about microvascular changes in smoking-related lung disease. We tested if
microvascular changes in the retina, kidneys and heart were associated with obstructive spirometry and low lung density on
computed tomography. The Multi-Ethnic Study of Atherosclerosis recruited participants age 45–84 years without clinical
cardiovascular disease. Measures of microvascular function included retinal arteriolar and venular caliber, urine albumin-to-
creatinine ratio and, in a subset, myocardial blood flow on magnetic resonance imaging. Spirometry was measured
following ATS/ERS guidelines. Low attenuation areas (LAA) were measured on lung fields of cardiac computed tomograms.
Regression models adjusted for pulmonary and cardiac risk factors, medications and body size. Among 3,397 participants,
retinal venular caliber was inversely associated with forced expiratory volume in one second (FEV1)( P ,0.001) and FEV1/
forced vital capacity (FVC) ratio (P=0.04). Albumin-to-creatinine ratio was inversely associated with FEV1 (P=0.002) but not
FEV1/FVC. Myocardial blood flow (n=126) was associated with lower FEV1 (P=0.02), lower FEV1/FVC (P=0.001) and greater
percentage LAA (P=0.04). Associations were of greater magnitude among smokers. Low lung function was associated with
microvascular changes in the retina, kidneys and heart, and low lung density was associated with impaired myocardial
microvascular perfusion. These cross-sectional results suggest that microvascular damage with end-organ dysfunction in all
circulations may pertain to the lung, that lung dysfunction may contribute to systemic microvascular disease, or that there
may be a shared predisposition.
Citation: Harris B, Klein R, Jerosch-Herold M, Hoffman EA, Ahmed FS, et al. (2012) The Association of Systemic Microvascular Changes with Lung Function and
Lung Density: A Cross-Sectional Study. PLoS ONE 7(12): e50224. doi:10.1371/journal.pone.0050224
Editor: Rory Edward Morty, University of Giessen Lung Center, Germany
Received June 19, 2012; Accepted October 22, 2012; Published December 20, 2012
Copyright:  2012 Harris et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This study was funded by National Institutes of Health R01-HL077612, R01-HL093081, and R01-HL075476. MESA is supported by N01-HC95159-
HC95169 and UL1-TR000040. A full list of participating MESA investigators and institutions can be found at http://www.mesa-nhlbi.org/. The funders had no role
in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: Funding was provided by federal sources, an interest in Vida Diagnostics (EA Hoffman) and a gift of a fish oil supplement, Omax3,
provided by Cenestra Health for a federally funded randomized clinical trial (RG Barr). These conflicts-of-interest do not alter the authors’ adherence to all the
PLOS ONE policies on sharing data and materials.
* E-mail: rgb9@columbia.edu
Introduction
Chronic obstructive pulmonary disease (COPD) recently
surpassed stroke as the third leading cause of death in the United
States [1]. Smoking is the major cause of COPD [2]; however, a
minority of smokers develop COPD [3]. Cigarette smoke injures
the airways and lung parenchyma by direct chemical exposure and
inflammation induced predominantly via neutrophils, macrophag-
es and T cells [4], [5].
Smoking is a major cause of endothelial dysfunction and
microvascular disease throughout the body, caused in part by
impairment of vascular endothelial growth factor (VEGF), with
subsequent generation of reactive oxygen species and diminished
nitric oxide release [6]. While it is known that smoking-related
microvascular disease contributes to end-organ damage in the
brain, kidney, heart and eyes [7], [8], it is unclear whether similar
microvascular changes in the lung may contribute to COPD
pathogenesis.
PLOS ONE | www.plosone.org 1 December 2012 | Volume 7 | Issue 12 | e50224Animal studies suggest that endothelial dysfunction might
contribute to COPD and emphysema [9], [10]. Several mecha-
nisms have been proposed both in vitro and in vivo [11], [12], [13],
[14]. Impaired flow mediated dilation (FMD) in large systemic
arteries was associated with early COPD and emphysema
[15],[16], as was impaired left ventricular filling [17] and
increased pulmonary perfusion heterogeneity [18]. Endothelial
microparticles reflective of endothelial apoptosis were increased in
smokers with isolated reductions in diffusing capacity [19] and in
COPD [20]. Together, these findings may suggest early pulmo-
nary endothelial and microvascular damage in patients with
COPD.
Whereas methods for assessing pulmonary microvascular
compromise in the general population are limited, validated
measures of systemic microvascular function are available for the
retina, kidneys and heart. Retinal microvascular abnormalities
include narrowing of retinal arterioles, predominantly from
hypertension, and widening of retinal venules, predominantly
from diabetes, inflammation and smoking. Both measures predict
cardiovascular events in middle-aged individuals [21], notably in
women (a 20 mm increase or decrease in retinal venular or
arteriolar caliber, respectively, was associated increased risk of
coronary heart disease) [22]. Microalbuminuria is a measure of
renal microvascular damage that predicts cardiovascular events
[23], as well as all-cause mortality in general population studies
[24]. A two-fold increase in urine albumin excretion was
associated with a relative risk of 1.29 for cardiovascular mortality,
and 1.12 for overall mortality [25]. Myocardial blood flow (MBF)
on magnetic resonance imaging (MRI) is a measure of cardiac
microvascular perfusion, impairments in which can cause myo-
cardial ischemia [26].
We examined the association of retinopathy, microalbuminuria
and myocardial blood flow, respectively, with lung function and
lung density on computed tomography (CT) in a large, multi-
ethnic cohort free of clinical cardiovascular disease. We hypoth-
esized that these measures of systemic microvascular changes were
associated with reduced lung function and lower lung density, and
that relationships would be of greater magnitude among smokers.
Materials and Methods
Study sample
The Multi-Ethnic Study of Atherosclerosis (MESA) is a
multicenter prospective cohort study of white, African-American,
Hispanic and Asian (predominantly of Chinese decent) adults [27].
In 2000–2002, MESA recruited 6,814 men and women ages 45–
84 years old from six U.S. communities: Forsyth County, NC;
Northern Manhattan and the Bronx, NY; Baltimore City and
Baltimore County, MD; St. Paul, MN; Chicago, IL; and Los
Angeles, CA. Exclusion criteria included clinical cardiovascular
disease, weight greater than 300 lbs, pregnancy and impediment
to long-term participation. All measures were ascertained at
baseline except as noted below.
The MESA Lung Study enrolled 3,965 MESA participants of
4,484 selected who were sampled randomly among those who
consented to genetic analyses, underwent baseline measures of
endothelial function, and attended an examination during the
MESA-Lung recruitment period in 2004–2006 (99%, 89%, and
91% of the MESA cohort, respectively). Asians were over-
sampled.
Similar to prior studies [17],[28], we excluded a priori 322
participants with a restrictive pattern of spirometry, defined as a
forced vital capacity (FVC) less than the lower limit of normal
(LLN) [29], with a forced expiratory volume in one second
(FEV1)/FVC ratio above the LLN, since the primary hypothesis
related to obstructive lung disease.
Ethics Statement
The protocols of MESA and all studies described herein were
approved by the Institutional Review Boards of all collaborating
institutions (Columbia University, New York, NY; Johns Hopkins
University, Baltimore, MD; Northwestern University, Chicago,
IL; University of California, Los Angeles, CA; University of
Minnesota, Twin Cities, MN; Wake Forest University, Winston-
Salem, NC) and the National Heart, Lung and Blood Institute
(NHLBI). Written informed consent was obtained from all study
participants.
Microvascular Measures in the Retina, Kidney and Heart
Retinal Vascular Caliber. Retinal vascular caliber was
measured from digital retinal photographs of both eyes of each
participant in 2002–03 [30]. All arterioles and venules coursing
through an area one half to one full disc diameter from the optic
disc margin (Figure 1) were measured using a computer-based
program by trained graders masked to participant characteristics
at a central reading center. Vascular caliber was summarized as
the central retinal artery equivalent (CRAE) and the central retinal
vein equivalent (CRVE), two well-established, reproducible
indicators of the average caliber of retinal vessels [30].
Urine Albumin-to-Creatinine Ratio and
Albuminuria. Urine albumin and creatinine were measured
at the baseline examination by nephelometry and the rate Jaffe
reaction. Spot urine albumin (mg/mL)-to-creatinine (mg/mL) ratios
(ACRs) were calculated. Previously published, gender-specific
categories of ACR were used to define albuminuria as high-
normal urine albumin excretion, microalbuminuria and macroal-
buminuria [31].
Myocardial Blood Flow. All participants at one field center
were asked to participate in the myocardial perfusion study; 222
agreed and underwent the study, of whom 126 met inclusion
Figure 1. Digital photograph a MESA participant’s retina
showing central retinal vascular caliber. The caliber of retinal
vessels is a calculated average of measurements of all arterioles and
venules coursing through an area one half to one full disc diameter
from the optic disc margin. Red shaded areas are used to compute the
central retinal artery equivalent (CRAE) and blue shaded areas are used
to compute the central retinal vein equivalent (CRVE).
doi:10.1371/journal.pone.0050224.g001
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gadolinium-enhanced cardiac MRI (Figure S1) at rest and again
during maximum adenosine-induced vasodilation (hyperemia)
[32]. All imaging was performed on a 1.5 T magnet with a 2-
coil anterior surface coil array positioned on the chest as a 2-coil
phased array integrated in the patient bed for posterior signal
reception. Image acquisition was gated electrocardiographically.
MBF was determined by model-independent deconvolution and
expressed as mL/g/min [33].
Spirometry
Spirometry was conducted in 2004–2006 and in accordance
with the American Thoracic Society/European Respiratory
Society guidelines [34] using a dry-rolling-sealed spirometer with
software that performed automated quality checks in real time
(Occupational Marketing, Inc., Houston, TX). All spirometry
exams were performed pre-bronchodilator and were reviewed by
one investigator [35].
Percent Low Attenuation Area
CT lung density was measured as percent lung low attenuation
area (%LAA) on the lung fields of cardiac CT scans, which imaged
Table 1. Characteristics of participants in the MESA Lung Study according to retinal vascular caliber as measured by central retinal
vein equivalent (CRVE).
Characteristic Quartile of Central Retinal Vein Equivalent
1
st Quartile
123.6–199.7 2
nd Quartile 199.7–214.2
3
rd Quartile
214.2–228.1 4
th Quartile 228.1–315.2
N=849 N=849 N=850 N=849
Age, mean (SD), years 63.7 (10.0) 60.9 (9.6) 60.2 ( 9.5) 59.7 ( 9.6)
Male gender, % 47.4 50.1 49.4 49.7
Race/ethnicity, %
- White (Non-Hispanic) 52.1 41.8 28.9 19.4
- African American 15.1 20.6 29.5 39.8
- Asian 15.2 16.5 17.1 16.6
- Hispanic 17.7 21.1 24.5 24.2
Education, years, %
- ,High school 12.5 14.4 18.6 19.7
- High school & beyond 87.5 67.6 81.4 80.3
Body mass index, mean (SD), kg/m
2 27.2 (4.9) 27.7 (4.9) 28.2 (5.4) 28.7 (5.6)
Waist circumference, mean (SD), cm 95.6 (13.6) 96.3 (13.6) 97.5 (13.9) 98.5 (14.7)
Height, mean (SD), cm 166.3 (10.0) 167.0 (10.3) 166.3 (10.1) 166.7 (9.8)
Cigarette smoking,%
- Never 51.5 52.5 46.1 39.2
- Past 41.1 38.2 38.9 36.4
- Current 7.4 9.3 15.1 24.4
Pack-years,* median (IQR) 15.0 (5.0, 33.0) 17.0 (6.0,32.3) 16.5 (6.3,34.2) 20.0 (7.6, 37.0)
Cotinine,{ median (IQR), ng/mL 2351 (226, 6479) 3058 (769,6012) 3891 (1127,7039) 4864 (1594, 9203)
Environmental tobacco exposure, % 41.6 39.4 44.0 46.6
Family history of emphysema, % 5.2 3.7 6.4 3.9
Asthma before age 45 years, % 7.5 7.4 8.1 8.5
Hypertension, % 44.6 40.4 40.3 41.3
Blood pressure, mean (SD), mmHg
- Systolic 125.2 (19.6) 124.1 (20.1) 124.1 (19.0) 124.2 (19.4)
- Diastolic 70.7 (10.2) 72.3 (10.1) 72.1 (9.7) 71.9 (9.8)
Diabetes mellitus, % 7.3 9.1 10.7 14.4
Fasting plasma glucose, median (IQR),mg/100 mL 95 (89,103) 95 (89,103) 97 (90,106) 98 (92,108)
High-density lipoprotein, mean (SD), mg/dL 53.6 (15.5) 51.4 (15.3) 50.4 (14.8) 48.3 (13.2)
Low-density lipoprotein, mean (SD), mg/dL 116.0 (29.8) 117.1 (30.7) 118.6 (30.9) 118.8 (31.8)
Abbreviations: SD=standard deviation; IQR=interquartile range.
Definitions: Hypertension=physician diagnosis of hypertension or systolic blood pressure .140 mmHg or diastolic blood pressure .90 mmHg; Diabetes
mellitus=physician diagnosis of diabetes or fasting plasma glucose .126 mg/dl.
*Among ever smokers.
{Among current smokers.
doi:10.1371/journal.pone.0050224.t001
Lung Function and Systemic Microvascular Changes
PLOS ONE | www.plosone.org 3 December 2012 | Volume 7 | Issue 12 | e50224approximately 70% of the lung volume from the carina to each
lung base. Cardiac CT scans were performed at full inspiration on
multi-detector (MD) and electron-beam CT scanners [36]. Two
scans were performed on each participant; the scan with the
higher air volume was used for analyses except in cases of
discordant scan quality, in which case the higher quality scan was
used.
Image attenuation was assessed using modified Pulmonary
Analysis Software Suite [37] at a single reading center by trained
readers without knowledge of other participant information. The
attenuation of each pixel in the lung regions was linearly corrected,
such that the mean attenuation outside the body was 21000 and
aortic was 50 Hounsfield Units (HU). %LAA was defined as the
percentage of the total voxels in the lung below 2910 HU. This
threshold was chosen based upon pathology comparisons [38] and
the generally mild degree of emphysema in the sample. Sensitivity
analyses were performed using %LAA defined as the percentage of
the total voxels in the lung below 2950 HU.
%LAA measures from the carina to lung base are highly
correlated (r=0.99) with full-lung measures on the same full-lung
scans in smokers [39]. %LAA measures from cardiac scans
correlated with those from full-lung scans from the same MESA
participants [40] and have been used in this cohort to confirm
multiple prior hypotheses [17], [28].
Smoking
Cigarette, cigar and pipe smoking was self-reported using
standardized questionnaire items [41]. Pack-years of cigarettes
were calculated as age of starting to age of quitting or current
age6(cigarettes-per-day/20). Cigarettes-per-day was assessed
twice over a 4-year interval by questionnaire; the greater of the
two measures were used in calculations. Current smoking was
confirmed by urinary cotinine levels (Immulite 2000 Nicotine
Metabolite Assay; Diagnostic Products Corp., Los Angeles, CA)
[42].
Covariates
Information on age, gender, race/ethnicity, educational attain-
ment, occupational exposure to dust, fumes, or smoke, environ-
mental tobacco smoke exposure, family history of emphysema,
medical history and medication use were self-reported using
standardized questionnaire items [41], [43], as recommended.
Height, weight and resting blood pressure were measured using
standard techniques, the latter using the Dinamap Monitor PRO
100 (Critikon, Tampa, FL). Serum glucose and lipids, including
high- and low-density lipoproteins, were measured after 12-hour
fast. The presence of diabetes mellitus was defined as fasting serum
glucose level .126 mg/dL or current use of any diabetes
medication.
Statistical Analysis
The cohort was stratified by quartile of CRVE for descriptive
purposes. Multivariate mean differences in lung function and
%LAA were estimated using generalized linear models that
regressed CRVE, CRAE, log-transformed ACR and MBF on
spirometric and %LAA measurements after adjustment for age,
gender, race/ethnicity, height, body mass index (BMI), waist and
hip circumference. For CT analyses, models were also adjusted for
scanner type and mAs. Multivariate models were then additionally
adjusted for cigarette smoking status, cigarette pack years and
urine cotinine, and subsequently the potential confounders listed
Table 2. Mean differences in lung function and percent low attenuation area (%LAA) by retinal vascular caliber as measured by
central retinal vein equivalent (CRVE).
Quartile of Central Retinal Vein Equivalent
Mean difference per
1 SD unit of CRVE (95% CI)
P-
value
1
st Quartile
123.6–199.7
2
nd Quartile
199.7–214.2
3
rd Quartile 214.2–
228.1
4
th Quartile
228.1–315.2
N=849 N=849 N=850 N=849
FEV1,mL
Model 1{ 0 237 278 2129 253 (269,238) ,0.001
Model 2{ 0 231 255 281 233 (248,218) ,0.001
Model 31 0 235 246 271 228 (243,214) ,0.001
FEV1/FVC,%*
Model 1{ 0 20.9 21.5 21.9 20.8 (21.0,20.5) ,0.001
Model 2{ 0 20.8 21.0 20.9 20.3 (20.6,20.1) 0.02
Model 31 0 20.9 20.9 20.8 20.3 (20.6,20.0) 0.04
LAA, %
Model 1{ 0 21.1 21.4 21.6 20.6 (21.0,20.2) 0.004
Model 2{ 0 21.1 21.2 21.0 20.3 (20.8, 0.1) 0.11
Model 31 0 21.1 21.1 21.0 20.3 (20.8, 0.1) 0.13
Abbreviations: SD=standard deviation; CRVE=Central Retinal Vein Equivalent; CI=confidence interval.
*Includes 16 fewer participants than FEV1 analysis.
{Model 1: Adjusted for age, gender, race/ethnicity, body mass index, height, waist and hip circumference and, for CT analyses, CT scanner type.
{Model 2: Adjusted for all the variables in model 1 plus cigarette smoking status, cigarette pack years and urine cotinine.
1Model 3: Adjusted for all the variables in model 2 plus cigar-years, pipe-years, environmental tobacco exposure, occupational exposure to dust, asthma before age 45,
family history of emphysema, chronic bronchitis, educational attainment, diabetes mellitus, fasting blood glucose, hypertension, systolic blood pressure, diastolic blood
pressure, high-density lipoprotein, low-density lipoprotein, C reactive protein, fibrinogen, aspirin use, beta blocker use, angiotensin II receptor blocker and/or
angiotensin converting enzyme inhibitor use, statin use, diuretic use, hormone replacement therapy use, bronchodilator use, oral or inhaled steroid use.
doi:10.1371/journal.pone.0050224.t002
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by smoking was tested with the – 2 log likelihood test of nested
models with and without interaction terms for smoking. Analyses
stratified by smoking status and restricted to individuals with
airflow limitation as defined by FEV1/FVC,0.7 were also
performed.
95% confidence intervals and P-values were estimated from
generalized linear models. A P-value,0.05 was considered to
indicate statistical significance. This threshold was not adjusted for
multiple comparisons; rather, all analyses are reported, as
recommended [44].
Statistical analyses were performed in SAS 9.2 (Cary, NC) and
R Statistical Software, version 2.10.0 (R Foundation, Vienna,
Austria) was used to generate graphs.
Results
Figure S2 shows the recruitment of 3,965 participants in the
MESA Lung Study and exclusions. There were no significant
differences between participants with and without retinal and
renal measures (data not shown) whereas those with MBF
measures were younger, more often White or Hispanic, and more
likely to report symptoms of chronic bronchitis (Table S1).
The overall sample of 3,643 was 61.1 years old at the baseline
examination and 51% women. Fourteen percent were current
smokers and 53% had ever smoked cigarettes. The mean FEV1
was 95.7% of predicted values and mean FEV1/FVC ratio was
74.5%.The median % LAA (,2910 HU) was 18.6 (interquartile
range, IQR, 10.0, 29.3).
Table 1 shows the characteristics of the study sample by quartile
of CRVE. Participants with a larger CRVE (4
th quartile) were
more likely to be African-American or Hispanic, of younger age,
higher BMI, and have lower education attainment. Tobacco
exposure and diabetes were associated with larger CRVE, as were
occupational exposure to dust and measures of inflammation.
Retinal Vascular Caliber
Table 2 shows measures of lung function stratified by quartiles
of CRVE and mean difference in lung function per standard
deviation (SD) unit of CRVE. There were highly significant
associations between CRVE and all spirometric measures. These
associations were somewhat attenuated after adjustment for
smoking variables but remained statistically significant after
adjustment for multiple measures of smoking in addition to other
potential confounders. The association of CRVE to the FEV1 was
linear without evidence for a threshold effect (Figure 2).
The relationship of CRVE with the FEV1 was modified by
smoking status (P-interaction=0.008): a 93 mL decrement in
current smokers (95% CI {2148, 238}; P,0.001), 48 mL
decrement in former smokers (95% CI {273, 223}; p,0.001),
and 4 mL decrement in never smokers per SD unit of CRVE
(95% CI {223, 15}; P=0.67).
There was no evidence that CRVE was associated with %LAA
after adjustment for smoking variables and other potential
confounders. CRAE was associated with neither lung function
nor %LAA (Table S2).
Figure 2. Multivariate association of the central retinal vein equivalent (CRVE) and the forced expiratory volume in one second
(FEV1). The association of CRVE to the FEV1 was linear in the fully adjusted model, and without evidence for a threshold effect. Covariates include
age, gender, race/ethnicity, height, BMI, waist and hip circumference, cigarette smoking status, pack-years, urine cotinine, cigar-years, pipe-years,
environmental tobacco exposure, occupational exposure to dust, asthma before age 45, family history of emphysema, chronic bronchitis, educational
attainment, diabetes mellitus, fasting blood glucose, hypertension, systolic blood pressure, diastolic blood pressure, high-density lipoprotein, low-
density lipoprotein, C reactive protein, fibrinogen, aspirin use, beta blocker use, angiotensin II receptor blocker and/or angiotensin converting
enzyme inhibitor use, statin use, diuretic use, hormone replacement therapy use, bronchodilator use, and oral or inhaled steroid use. Dotted lines are
95% confidence intervals.
doi:10.1371/journal.pone.0050224.g002
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Table 3 shows measures of lung function and %LAA by urine
albumin excretion (UAE) as defined by degree of albuminuria.
Mean difference in FEV1 was 225 mL per SD unit of log-
transformed ACR (95% CI {240, 29}, P=0.002).There were
highly significant associations of UAE and ACR, respectively, to
the FEV1 and FVC before and after adjustment for smoking
variables and other covariates, but not to the FEV1/FVC ratio.
The association of ACR to the FEV1 was linear on a log scale
(Figure 3).
Smoking status did not modify the associations of ACR with
lung function (P-interaction.0.10) although the magnitude of the
association was greater in smokers: a decrement in the FEV1 of
67 mL (95% CI {2121, 213}; P=0.02) in current smokers,
48 mL (95% CI {271, 226}; P,0.001) in former smokers and
18 ml (95% CI { 236, 0.1}; P=0.06) in never smokers.
Associations with %LAA were not statistically significant in fully
adjusted models for UAE (Table 3) or for ACR (20.3% per 1 SD
unit of ACR, 95% CI {20.8, 0.1}; P=0.13).
Myocardial Perfusion
Mean differences in lung function and %LAA per SD unit of
resting and hyperemic MBF are shown in Table 4. In fully
adjusted models, hyperemic MBF was positively associated with
measures of airflow limitation (both FEV1 and FEV1/FVC) and
inversely associated with %LAA. Findings were essentially
unchanged after additional adjustment of hyperemic MBF for
resting MBF (FEV1 112 mL, 95% CI {14, 210}; P-value 0.03;
FEV1/FVC 2.9%, 95% CI {1.1, 4.6}; P=0.002; and %LAA
22.6%, 95% CI {25.5, 0.2}; P=0.07). In addition, %LAA was
associated with resting MBF. Associations were qualitatively of
greater magnitude among smokers (data not shown).
Supplemental Analyses
After the exclusion of participants with diabetes, the magnitude
of associations for the FEV1 and FEV1/FVC ratio generally
increased. Exclusion of participants with hypertension had little
impact on the results and there was no evidence for effect
modification by race/ethnicity or gender (data not shown).
The relationship between CRVE and FEV1/FVC was similar
among 783 participants with airflow limitation compared to all
participants but did not attain statistical significance (20.02% per
1 SD unit CRVE, P=0.06). The association between FEV1 and
ACR among those with airflow limitation was attenuated (a
decrement in FEV1 of 13 mL per 1 SD unit ACR; P=0.58).
Using a threshold of 2950 HU to define %LAA, the association
with resting MBF remained significant (P=0.004), the relationship
with hyperemic MBF did not (P=0.12), and the statistical
significance of all other results were unchanged (data not shown).
Sensitivity analysis using an inflated measure of pack-years also did
not alter the results.
Discussion
Microvascular changes in the retina, kidneys and heart were
associated with decrements in lung function in this large,
population-based cohort free of clinical cardiovascular disease.
In addition, impaired myocardial microvascular function on MRI
scanning was associated with lower lung function and lower lung
density on CT scan.
Table 3. Mean differences in lung function and percent low attenuation area (%LAA) by renal function, as measured by urine
albumin excretion (UAE) categories defined by albumin-to-creatinine ratio (ACR).
Urine Albumin Excretion P-value
None High normal Micro-albuminuria Macro-albuminuria
N=2802 N=396 N=394 N=35
FEV1,mL
Model 1{ 0 279 2106 2109 ,0.0001
Model 2{ 0 280 297 2108 0.0002
Model 31 0 258 270 249 0.0006
FEV1/FVC,%*
Model 1{ 0 20.6 20.7 1.1 0.18
Model 2{ 0 20.6 20.5 1.1 0.65
Model 31 0 20.5 20.7 0.5 0.12
LAA, %
Model 1{ 0 20.3 22.1 21.2 0.0022
Model 2{ 0 20.4 22.1 21.5 0.24
Model 31 0 20.1 21.3 20.3 0.11
Abbreviations: SD=standard deviation; ACR=albumin-to-creatinine ratio; CI=confidence interval.
Definitions: 1) High normal urine albumin excretion: ACR 9–16.9 mg/g in men and 13–24.9 mg/g in women; 2) Microalbuminuria: ACR 17–250 mg/g in men and 25–
354.9 mg/g in women; and 3) Macroalbuminuria: ACR $250 mg/g in men and $355 mg/g in women.
*Includes 17 fewer participants than FEV1 analysis.
{Model 1: Adjusted for age, gender, race/ethnicity, body mass index, height, waist and hip circumference and, for CT analyses, CT scanner type.
{Model 2: Adjusted for all the variables in model 1 plus cigarette smoking status, cigarette pack years and urine cotinine.
1Model 3: Adjusted for all the variables in model 2 plus cigar-years, pipe-years, environmental tobacco exposure, occupational exposure to dust, asthma before age 45,
family history of emphysema, chronic bronchitis, educational attainment, diabetes mellitus, fasting blood glucose, hypertension, systolic blood pressure, diastolic blood
pressure, high-density lipoprotein, low-density lipoprotein, C reactive protein, fibrinogen, aspirin use, beta blocker use, angiotensin II receptor blocker and/or
angiotensin converting enzyme inhibitor use, statin use, diuretic use, hormone replacement therapy use, bronchodilator use, oral or inhaled steroid use.
doi:10.1371/journal.pone.0050224.t003
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microvascular disease in the retinal, renal and myocardial
circulations. The first, retinal vascular caliber, has been widely
used as a marker for changes in the microvasculature [45], [46].
No prior studies have examined retinal vascular caliber in COPD,
to our knowledge, although one study found impaired hemody-
namic changes of extraocular orbital arteries in COPD patients
compared to healthy controls [47].
Retinal venular caliber, which is typically considered reflective
of early diabetic microvascular changes [46], was linearly related
to an obstructive pattern of spirometry. In studies of the effect of
hyperglycemia on retinal blood flow, venular vasodilation is
thought to occur due to oxidative stress and local ‘‘pseudohy-
poxia’’ [48]. In addition, endothelial dysfunction, abnormal nitric
oxide levels and inflammatory mediators interfere with vascular
auto-regulation, leading to vasodilation of the retinal veins [49].
Retinal venular caliber in MESA was associated with brachial
artery FMD, a measure of endothelial dysfunction [50], and we
have previously shown that brachial artery FMD is associated with
lung function and %LAA [15]. The observed association of CVRE
with lung function may therefore reflect endothelial dysfunction or
hypoxemia, although it is unlikely that many participants in this
population-based study were significantly hypoxemic.
In contrast, there was no evidence for an association of lung
function with retinal arteriolar caliber, which is typically narrowed
in hypertension and hypertensive arteriopathies [30].
The second microvascular measure, albuminuria, reflects
endothelial dysfunction and microvascular damage in the renal
circulation [51]. A prior small study found a significant
relationship between microalbuminuria and COPD exacerbations
[52], and in another, microalbuminuria was greater among 129
COPD patients compared to 51 controls [53]. The lack of
association in the present study between albuminuria and FEV1/
FVC may reflect residual confounding by obesity. Although we
did not detect an association with low lung density in this healthy
cohort, severe emphysema, as measured by %LAA on quantitative
Table 4. Mean differences in lung function and percent low attenuation area (%LAA) by myocardial blood flow (MBF) at rest and
during hyperemia.
Resting MBF, ml/g/min (95% CI) P-value Hyperemic MBF, ml/g/min (95% CI) P-value
FEV1,mL
Model 1{ 150 (2226, 526) 0.43 62 (247, 171) 0.26
Model 2{ 112 (2245, 469) 0.54 94 (28, 197) 0.07
Model 31 118 (2244, 481) 0.52 113 (16, 211) 0.02
FEV1/FVC,%
Model 1{ 5.7 (20.6, 11.9) 0.08 2.0 (20.2, 3.8) 0.03
Model 2{ 4.3 (21.5, 10.0) 0.14 2.5 (0.8, 4.1) 0.003
Model 31 5.1 (21.7, 11.8) 0.14 3.0 (1.2, 4.7) 0.001
LAA, %
Model 1{ 29.4 (219.6, 0.9) 0.07 21.7 (24.6, 1.3) 0.27
Model 2{ 28.1 (217.7, 1.5) 0.10 21.4 (24.2, 1.4) 0.34
Model 31 214.7 (225.4, 23.9) 0.008 23.1 (26.0, 0.1) 0.04
Abbreviations: SD=standard deviation; MBF=myocardial blood flow; CI=confidence interval;
{Model 1: Adjusted for age, gender, race/ethnicity, body mass index, height, waist and hip circumference and, for CT analyses, CT scanner type.
{Model 2: Adjusted for all the variables in model 1 plus cigarette smoking status, cigarette pack years and urine cotinine.
1Model 3: Adjusted for all the variables in model 2 plus cigar-years, pipe-years, environmental tobacco exposure, occupational exposure to dust, asthma before age 45,
family history of emphysema, chronic bronchitis, educational attainment, diabetes mellitus, fasting blood glucose, hypertension, systolic blood pressure, diastolic blood
pressure, heart rate, high-density lipoprotein, low-density lipoprotein, C reactive protein, fibrinogen, aspirin use, beta blocker use, angiotensin II receptor blocker and/or
angiotensin converting enzyme inhibitor use, statin use, diuretic use, hormone replacement therapy use, bronchodilator use, oral or inhaled steroid use.
doi:10.1371/journal.pone.0050224.t004
Figure 3. Multivariate association of the log-transformed
albumin-to-creatinine ratio (ACR) and the forced expiratory
volume in one second (FEV1). The association of ACR to FEV1 was
linear on a log scale in the fully adjusted multivariate model. Covariates
include age, gender, race/ethnicity, height, BMI, waist and hip
circumference, cigarette smoking status, pack-years, urine cotinine,
cigar-years, pipe-years, environmental tobacco exposure, occupational
exposure to dust, asthma before age 45, family history of emphysema,
chronic bronchitis, educational attainment, diabetes mellitus, fasting
blood glucose, hypertension, systolic blood pressure, diastolic blood
pressure, high-density lipoprotein, low-density lipoprotein, C reactive
protein, fibrinogen, aspirin use, beta blocker use, angiotensin II receptor
blocker and/or angiotensin converting enzyme inhibitor use, statin use,
diuretic use, hormone replacement therapy use, bronchodilator use,
and oral or inhaled steroid use. Dotted lines are 95% confidence
intervals.
doi:10.1371/journal.pone.0050224.g003
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filtration rate in smokers [54].
The third measure, myocardial perfusion, is thought to be
affected by impairment of smooth muscle relaxation and
endothelial dysfunction at a microcirculatory level in the absence
of coronary epicardial stenosis [32]. In the present study, coronary
vasodilatation with adenosine demonstrated an association of
hyperemic MBF with lung function, which suggests impaired
cardiac microvascular perfusion. The relationship of resting MBF
to %LAA also suggests impairment of microvascular blood flow in
the heart. This association is unlikely to reflect any epicardial
abnormalities since there is no evidence for an association of
%LAA with coronary artery calcium in this cohort [28]. A
previous thallium-201 imaging study reported reversible perfusion
defects in COPD patients attributable to reduced thallium uptake
due to cellular dysfunction [55]. The present study adds to this
finding by linking the reduced contrast uptake to microvascular
dysfunction, as gadolinium is an extracellular, blood-borne tracer
that allows direct estimation of MBF and microvascular function
without regard to cellular function.
Taken in totality, findings from this large study with a unique
combination of microvascular measures suggest that there are
diffuse systemic microvascular changes associated with decrements
in lung function in healthy individuals, especially in smokers.
While the cross-sectional design of the study prevents definitive
conclusions about causality and the direction of the association (i.e.
whether microvascular changes contribute to airflow limitation or
the reverse), we speculate smoking could cause microvascular
disease with resultant end-organ damage to the lungs via related
mechanisms by which it causes microvascular disease in the
systemic circulation. Although this concept is relatively unexplored
in COPD as classically defined by airflow obstruction, this
mechanism is biologically plausible given the proximal dose of
tobacco smoke to the pulmonary circulation and the small
probability that the pulmonary microcirculation is immune to
the effects of tobacco smoke.
The few existing biopsy studies on pulmonary microvascular
structure in COPD demonstrate microvascular remodeling and
redistribution [56], [57], [58], [59] and functional studies show
that airway blood flow and vasodilator response is reduced in
COPD [60]. In a mouse model, tobacco smoke-induced
alterations in lung vascular structure and function preceded
emphysema, and were independent of hypoxia [61].
Alternatively, decrements in lung function and structure might
cause systemic microvascular disease, potentially via hypoxemia
[53], which was not measured in the present study. Another
possibility is a shared susceptibility to cigarette smoke; that is,
persons with a susceptibility to smoking-related systemic micro-
vascular disease are also susceptible to smoking-related lung
disease. For example, genome-wide association studies of lung
function have found significant associations for variants in the
receptor for advanced glycation end products (RAGE) gene, which
is also implicated in microvascular disease [62].
There are several limitations to our study. There is the potential
for residual confounding in observational studies, particularly by
smoking. However, dose of current smoking was precisely
measured by the assessment of cotinine levels and sensitivity
analyses using inflated measures of pack-years yielded similar
results (data not shown). An additional limitation is that %LAA
was assessed on cardiac scans, an approach which has been
previously validated in this cohort and which has confirmed prior
hypotheses [17], [28], [40]. Smoking-related emphysema has an
apical predominance and the apices were less accurately measured
than the bases in the current study because the coronary calcium
scans assessed the lower 70% of the lung. This may explain why
associations of the retina and kidney were more evident for
measures of lung function than lung density, which is the opposite
of what we found in a study of endothelial dysfunction among
smokers using full-lung scans [15]. Finally, spirometry was
measured approximately four years after the other measures,
which could have resulted in temporally dissociated relationships;
however, this is unlikely to have had a significant impact on the
results given the small change in spirometric values over this time
period. Despite these limitations, the large number of participants,
including 783 with airflow limitation, contributes to both the
power and precision of findings.
In conclusion, low lung function was associated with microvas-
cular changes in the retina, kidney and heart, and low lung density
was associated with impaired myocardial microvascular perfusion.
These findings suggest that obstructive decrements in lung
function may be characterized by defects in the microvascular
circulation, which may provide an important link between
cardiovascular and pulmonary disease.
Supporting Information
Figure S1 Measurement of myocardial blood flow (MBF) using
magnetic resonance imaging (MRI).Figure S1a. The three MRI
images from a MESA participant show selected phases for
measurement of MBF depicting 1) the transit of a contrast bolus
in the right ventricle, 2) peak enhancement of the left ventricular
blood pool, and 3) maximum myocardial enhancement. Figure
S1b–d. Signal intensity versus time curves were generated in a
region of the left ventricle (Fig. S1b) and the anterior myocardial
sector (Fig. S1d). MBF was determined by optimizing the shape of
the maximum tissue impulse response (Fig. S1c) in conjunction
with arterial input (convolution operator symbolized by : in Fig.
S1b). The line of best fit is shown in Fig. S1d.
(TIF)
Figure S2 Recruitment of the MESA Lung Study and exclusions
for the current study sample. 3,965 participants were recruited
from the overall MESA cohort to the MESA Lung Study.
Subsequent exclusions based on available/acceptable measure-
ments and restriction on spirometry yielded 3,397 participants in
the retinal analysis and 3,627 participants in the renal analysis.
Given the availability myocardial blood flow (MBF) measurements
in a subset of MESA-Lung participants at one study site, there
were 126 participants available for cardiac analysis.
(TIF)
Table S1 Comparison of characteristics of participants in overall
sample with and without myocardial perfusion measurements.
(DOCX)
Table S2 Lung function and percent low attenuation area
(%LAA) by retinal vascular caliber as measured by central retinal
artery equivalent (CRAE).
(DOCX)
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